Table 2.
Clinicopathological features of melanoma patients with at least 5 years of follow-up (n = 664). SSM, superficial spreading melanoma; NM, nodular melanoma; LM, lentigo maligna; LMM, lentigo maligna melanoma; ALM, acral lentiginous melanoma; nd: no data.
| All Patients | Women | Men | |
|---|---|---|---|
| N | 664 | 360 | 304 |
| Age at diagnosis | Range 22–93 (median: 58) |
Range 22–93 (median: 53) |
Range 22–93 (median: 62) |
| Disease evolution | |||
| Disease free | 469 | 275 | 194 |
| Metastasis | 195 | 85 | 110 |
| Stage at diagnosis (AJCC 8th edition) | |||
| In situ | 91 | 53 | 38 |
| IA | 238 | 135 | 103 |
| IB | 91 | 56 | 35 |
| IIA | 61 | 33 | 28 |
| IIB | 38 | 22 | 16 |
| IIC | 42 | 19 | 23 |
| IIIA | 17 | 7 | 10 |
| IIIB | 11 | 5 | 6 |
| IIIC | 46 | 16 | 30 |
| IIID | 3 | 0 | 3 |
| IV | 13 | 7 | 6 |
| nd | 13 | 7 | 6 |
| Melanoma subtypes | |||
| SSM | 362 | 196 | 166 |
| NM | 100 | 53 | 47 |
| LM | 19 | 8 | 11 |
| LMM | 21 | 13 | 8 |
| ALM | 37 | 24 | 13 |
| Others | 29 | 17 | 13 |
| nd | 96 | 49 | 46 |
| Breslow Thickness (mm) | |||
| 0 | 88 | 49 | 39 |
| ≤1 | 257 | 146 | 111 |
| >1–2 | 116 | 64 | 52 |
| >2–4 | 92 | 52 | 40 |
| >4 | 85 | 33 | 52 |
| nd | 26 | 16 | 10 |
| Location | |||
| Head/Neck | 86 | 35 | 51 |
| Trunk | 265 | 105 | 160 |
| Upper limb | 84 | 52 | 32 |
| Lower limb | 165 | 124 | 41 |
| Hands/foot | 42 | 31 | 11 |
| Others | 12 | 8 | 4 |
| nd | 10 | 5 | 5 |